drugset / Trial / NCT02355665
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
Phase 3
Completed
1198 enrolled
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
GlaxoSmithKline · collabMcNeil AB · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of a novel nicotine product for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.
Timeline
- Start
- 2015-01-31
- Primary completion
- 2015-09-30
- Completion
- 2016-02-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine | Unknown | — | Other |